Nurix Therapeutics, Inc. — 144 Filings
26 144 filings on record
This page lists all 144 filings submitted to the SEC by Nurix Therapeutics, Inc. (NRIX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Nurix Therapeutics, Inc. has filed 26 144 documents with the SEC since 2012. To view all SEC filings by Nurix Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-26-001992 | Mar 2, 2026 | — |
| 144 | — | 0001950047-26-001040 | Feb 9, 2026 | — |
| 144 | — | 0001950047-25-010507 | Dec 18, 2025 | — |
| 144 | — | 0001950047-25-009272 | Nov 24, 2025 | — |
| 144 | — | 0001950047-25-008397 | Nov 3, 2025 | — |
| 144 | — | 0001950047-25-005336 | Aug 1, 2025 | — |
| 144 | — | 0001950047-25-002704 | May 2, 2025 | — |
| 144 | — | 0001950047-25-001394 | Mar 3, 2025 | — |
| 144 | — | 0001950047-25-000527 | Jan 31, 2025 | — |
| 144 | — | 0001950047-25-000031 | Jan 2, 2025 | — |
| 144 | — | 0001950047-24-009299 | Dec 2, 2024 | — |
| 144 | — | 0001950047-24-008089 | Nov 4, 2024 | — |
| 144 | — | 0001950047-24-008041 | Nov 1, 2024 | — |
| 144 | — | 0001950047-24-008001 | Nov 1, 2024 | — |
| 144 | — | 0001950047-24-007510 | Oct 1, 2024 | — |
| 144 | — | 0001950047-24-006749 | Sep 3, 2024 | — |
| 144 | — | 0001950047-24-006506 | Aug 26, 2024 | — |
| 144 | — | 0001950047-24-006505 | Aug 26, 2024 | — |
| 144 | — | 0001950047-24-005769 | Aug 1, 2024 | — |
| 144 | — | 0001950047-24-005751 | Aug 1, 2024 | — |
| 144 | — | 0001950047-24-005117 | Jul 1, 2024 | — |
| 144 | — | 0001950047-24-004908 | Jun 20, 2024 | — |
| 144 | — | 0001950047-24-004350 | Jun 3, 2024 | — |
| 144 | — | 0001950047-24-003319 | May 2, 2024 | — |
| 144 | — | 0001950047-24-001051 | Feb 16, 2024 | — |
| 144 | — | 0001950047-23-006287 | Dec 19, 2023 | — |